IRS1 phosphorylation underlies the non-stochastic probability of cancer cells to persist during EGFR inhibition therapy

The PRIDE database and related tools and resources in 2019: improving support for quantification data

Yasset Pérez‐Riverol, Attila Csordás, Jingwen Bai et al. · Nucleic Acids Research · 2018 · 7.4K citations · Full text

Life Sciences, Biochemistry, Bioinformatics +15

Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain

William Pao, Vincent A. Miller, Katerina Politi et al. · PLoS Medicine · 2005 · 3.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Bacterial Persistence as a Phenotypic Switch

Nathalie Q. Balaban, Jack Merrin, Remy Chait et al. · Science · 2004 · 3K citations

Life Sciences, Biology, Microbiology +16

A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations

Sreenath V. Sharma, Diana Lee, Bihua Li et al. · Cell · 2010 · 2.8K citations · Full text

Life Sciences, Cancer Biology, Oncology +14

Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

Vasanthi S. Viswanathan, Matthew J. Ryan, Harshil Dhruv et al. · Nature · 2017 · 2K citations · Full text

Medicine, Cancer Biology, Oncology +16